Covid-19 treatment: Sun Pharma gets DCGI approval for Nafamostat clinical trial in patients


Team Udayavani, May 30, 2020, 4:04 PM IST

The Drug Controller General of India has approved Sun Pharmaceutical Industries Ltd’s clinical trial with nafamostat mesilate in covid-19 patients

Nafamostat is approved in Japan for improvement of acute symptoms of pancreatitis and treatment of disseminated intravascular coagulation (DIC)

Scientists from the University of Tokyo in Japan and Leibniz Institute for Primate Research in Germany recently demonstrated that Nafamostat at very low concentrations suppresses a protein that the Covid-19 virus uses to enter human lung cells.

Dilip Shanghvi, Managing Director, Sun Pharma said, “Sun Pharma is constantly evaluating potential targets that can be explored for treating Covid-19 patients. Nafamostat has shown promising data against SARS-CoV-2 virus in in-vitro studies conducted by three independent groups of scientists in Europe, Japan and South Korea. We believe it holds promise in the treatment of Covid-19 patients

Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

SC says firecracker ban not against any community

Nine killed in J&K’s Doda after bus falls into gorge; PM announces ex-gratia of Rs 2 lakh

Puttur: RSS leader accused of raping minor Dalit girl surrenders

IT Min seeks details of algorithm, processes used by FB amid hate speech allegations: Sources

Bengaluru to host two-day conference of tourism, culture ministers of southern region

Ind vs Pak T20 WC: Those celebrating Pakistan’s win will face sedition charges, says Yogi Adityanath

Covid-19: Officials conduct surprise inspection at schools in Mangaluru

Related Articles More

Wild Himalayan fig may be used as natural pain reliever, animal study finds

Your unvaccinated friend is roughly 20 times more likely to give you COVID

Mild to moderate cases in home isolation can infect only one-third contacts: WHO-MAMC study

Two patients with serious issues stemming from obesity undergo surgery using robot-assisted tool

Ivermectin: Misuse against COVID risks undermining its use for other diseases

MUST WATCH

Karnataka rajyotsava celebrations: Mass rendition of Kannada songs at Udupi DC Office

Tiger swimming in kabini back water at mysore

Alerts for tourists visiting the Ettina Bujja

News Bulletin 27-10-2021

Why is organ donation important?


Latest Additions

SC says firecracker ban not against any community

Rajasthan ranks 2nd after Karnataka on State Energy Efficiency Index 2020

SC says firecracker ban not against any community

Nine killed in J&K’s Doda after bus falls into gorge; PM announces ex-gratia of Rs 2 lakh

Puttur: RSS leader accused of raping minor Dalit girl surrenders

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.